back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2023-05-08 10:05 Tx date 2023-05-04 |
$BLCO
Bausch + Lomb Corporation |
Von Eschenbach, Andrew Charles
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+12,857 vol |
12,857 | |
| Filed 2023-04-27 16:50 Tx date 2023-04-24 |
$BLCO
Bausch + Lomb Corporation |
Von Eschenbach, Andrew Charles
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$214,000
+12,500 vol $17.12 each |
12,500 | |
| Filed 2023-04-27 16:50 Tx date 2022-05-05 |
$BLCO
Bausch + Lomb Corporation |
Von Eschenbach, Andrew Charles
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-04-27 16:50 Tx date 2023-04-24 |
$BLCO
Bausch + Lomb Corporation |
Von Eschenbach, Andrew Charles
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
$-214,000
-12,500 vol $17.12 each |
0 | |
| Filed 2022-05-17 18:52 Tx date 2022-05-12 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Von Eschenbach, Andrew Charles
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$33,753
+3,293 vol $10.25 each |
8,500 | |
| Filed 2022-05-17 18:52 Tx date 2022-05-12 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Von Eschenbach, Andrew Charles
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$17,496
+1,707 vol $10.25 each |
5,207 | |
| Filed 2022-05-12 09:16 Tx date 2022-05-10 |
$BLCO
Bausch + Lomb Corporation |
Von Eschenbach, Andrew Charles
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+12,500 vol |
12,500 | |
| Filed 2022-05-12 09:16 Tx date 2022-05-05 |
$BLCO
Bausch + Lomb Corporation |
Von Eschenbach, Andrew Charles
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-08-09 11:53 Tx date 2021-08-05 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Von Eschenbach, Andrew Charles
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$36,316
+1,400 vol $25.94 each |
3,500 | |
| Filed 2021-05-03 19:57 Tx date 2021-04-30 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Von Eschenbach, Andrew Charles
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$249,991
+7,645 vol $32.70 each |
35,147 | |
| Filed 2020-05-04 11:10 Tx date 2020-05-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Von Eschenbach, Andrew Charles
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+11,037 vol |
27,502 | |
| Filed 2020-03-12 10:07 Tx date 2020-03-10 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Von Eschenbach, Andrew Charles
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$19,996
+1,100 vol $18.18 each |
2,100 | |
| Filed 2019-05-06 11:57 Tx date 2018-10-29 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Von Eschenbach, Andrew Charles
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+5,832 vol |
5,832 | |
| Filed 2019-05-06 11:48 Tx date 2019-05-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Von Eschenbach, Andrew Charles
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$249,981
+10,633 vol $23.51 each |
16,465 | |
| Filed 2019-05-06 11:47 Tx date 2018-10-29 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Von Eschenbach, Andrew Charles
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-03-13 Tx date 2018-10-29 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Von Eschenbach, Andrew Charles
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
1,000 |